Tayanes, Gemma .
HRN: 28-80-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2026
MUPIROCIN 2%, 15G (TUBE)
04/07/2026
04/14/2026
TOPICAL
Pea Sized
OD
S/P Pelvic Lap
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: